New Delhi, 18 October. Providing major relief to cancer patients, the Central Government has capped the trade margin on 137 non-scheduled anti-cancer drugs at 30 percent of the maximum retail price (MRP). Due to this decision of the National Pharmaceutical Pricing Authority (NPPA), the prices of many anti-cancer drugs have been reduced by up to 70 percent (…)
